Pharmaceutical Ministry of Commerce - Intl Medical Information November 05,2010 to November 29,2010

Search and Discover China Trade Knowledge from Trusted Sources™

Current Language: English

Search this Author

Vaccine market new products to...

Now the world capacity of the vaccine market has been greatly increased, compared with 2000, the vaccine market capacity has increased 3 times, it is indeed all areas of the fastest growing pharmace...

2010, waiting for FDA approved...

FDA will be completed in the fourth quarter of 2010 drugs approved several important decisions. They are for the treatment of sodium oxybate fibromyalgia, symptoms of pseudobulbar palsy treatment o...

U.S. Food and Drug Administrat...

Higher generic utilization rate in the United States, so that with the FDA to ensure that imitation is imitation of innovative products as safe and effective essential FDA Center for Drug Evaluati...

The field of international pha...

Editor's Note According to the 2009 annual performance report, the world's major pharmaceutical companies have different levels of positive growth and profitability. However, we also see many l...

India to introduce new regulat...

The recent emergence of super-resistant bacteria causing widespread panic in the world. Indian Drug Review and Drug Administration has agreed to rules of the Commission to adopt new sales of antibi...

Teva2.65 billion acquisition o...

Merck (Merck KGaA) to the Israeli pharmaceutical company Teva to sell its health care subsidiary of female Theramex. Teva will rely on its internal resources to complete the acquisition project, ...

Paris medical records show the...

Number of participants increased by 14%, to 1934 exhibitors UBMLive11 leading exhibition organizers announced 10 January, in Paris, France's flagship medical exhibition CPhIWorldwide2010 the reco...

Singapore 3 new class of drugs...

Three drugs were the Lion City to ban new psychedelic drug as may be ecstasy drug users were classified as A-level Government of Singapore there are two types of drugs are still in circulation to su...

U.S. FDA issued rules to stren...

FDA recently issued a new rule aimed at strengthening the agency obtained in clinical trials of experimental drugs or medical product safety information quality. New rules require, initiate clinic...

Japanese drug maker Otsuka Hol...

Japan's Otsuka Pharmaceutical Group Holdings (Otsuka Holdings) plans to December in the local market, IPO (initial public offering) market, to be raised through this transaction is about 28 bil...

Next year the global disposabl...

In addition to developed countries and countries in the region major global markets disposable medical devices, some previously neglected countries and regions have gradually become the new market o...

For the Indian pharmaceutical ...

A research company Frost & Sullivan analysts predict that in the near future the international pharmaceutical giant Indian companies will buy more products, and pharmaceutical companies in China but...

Tianyuan Bio Novartis acquisit...

November 17, Novartis cash Zhejiang Tianyuan Bio approval year deadline has passed, but the late announcement of the Ministry of Commerce of the outcome, so that cross-border merger cases cast a sha...

Occupy the major markets in Eu...

Editor's note: Lecithin is capable of regulating blood lipids, anti-aging, and promote bowel movements and anti-constipation Results and prevention of diabetes and other health benefits, for a "thr...

Generic drug is in the world "...

Generic drug is in the world "golden age", for four reasons: 1, a large number of drugs lose patent, generic drugs to share the feast; 2, new drugs to reduce the lack of blockbuster; 3, overwhelmed ...

FDA to tighten standards for g...

Core Tip: FDA Center for Drug Evaluation and Research (CDER) Director Dr. Janet Woodcock • recently said, FDA may tighten between generic and brand drugs equivalent standards. Cheap generic dr...

New Three-quarter profit surge...

Core Tip: Third-quarter net income soared to 31.3 billion rupees, about $ 67,000,000, compared to 1.17 billion rupees a year earlier. Ranbaxy Pharmaceuticals announced its third quarter financial ...

The pharmaceutical industry hi...

Core Tip: The German drug pricing regulations change is the Government as part of health care reform. Designed to force pharmaceutical companies through price negotiations with health insurers to c...

German health reform cut drug ...

Core Tip: German lower house of parliament passed a new draft has been trying to control the prices of new prescription drugs. According to InPharm.com 11 月 12th, the German lower house of parli...

British government abandoned p...

Core Tip: In the public consultation, the British government recently decided to abandon the controversial practice in the community, voluntary health care in the generic drug substitution program. ...

Asia-Pacific pharmaceutical dr...

Thomson Reuters (Thomson Reuters)'s business CMR International has released a new report, Asia-Pacific pharmaceutical companies are the business models from the production of generic drugs to hig...

U.S. biopharmaceutical R & D S...

PhRMA2010 biopharmaceutical industry reports - U.S. biopharmaceutical R & D Speed In 2009, the U.S. drug research and bio-pharmaceutical company still maintains R & D the largest investor in the...

Singapore developed a green me...

Singapore, Singapore, November 18 hearing researchers have developed a "green chemical" Pharmaceutical Law, the ability to convert carbon dioxide into the air in a can kill cancer cells, lower chole...

Abbott Laboratories from Janua...

Abbott on October 20, 2010 released the 2010 three-quarter reports and results of 1-9 months. Q3 2010 sales reached 8.675 billion U.S. dollars, up 11.8%, of which overseas sales reached 4.813 billi...

Novartis Group's 2010 results ...

Novartis Pharmaceuticals Corporation October 21, 2010 Q3 2010 release, and the performance of 1-9 months. 2010 Q3 sales revenue reached 12.578 billion U.S. dollars, up 13% and net profit of $ 2,919...

Roche January-September sales

October 14, 2010 the Swiss pharmaceutical company Roche, the company announced in January 1-9, 2010 financial report. The situation in the global economic recession, the pharmaceutical industry sho...

Pharmaceutical company AstraZe...

AstraZeneca Pharmaceuticals in October 28, 2010 the Company announced Q3 2010 results in January and 1-9. Q3 2010 sales of the company fell 2% (CER), reached 7.898 billion U.S. dollars, may be se...

Johnson & Johnson Pharmaceutic...

Johnson & Johnson pharmaceutical company in the United States October 19, 2010 the Company announced Q3 2010 financial situation. 3-quarter sales fell 0.7%, to 150 billion U.S. dollars. U.S. sales...

GlaxoSmithKline sales from Jan...

Glaxo SmithKline October 21, 2010 the Company announced Q3 2010 results and the situation of 1-9 months. 1-9 month revenues of 21.195 billion pounds, up 5% (in sterling terms), if not epidemics o...

Eli Lilly and Company sales fr...

Eli Lilly and Company (Eli Lilly) 7 月 22 announced results for the second quarter of 2010. Compared with a year earlier, net income for the quarter jumped Eli Lilly and Company 16%, reaching 1....